Meyers Michael L. 4
4 · Syndax Pharmaceuticals Inc · Filed Mar 22, 2019
Insider Transaction Report
Form 4
Meyers Michael L.
SVP, Chief Development Officer
Transactions
- Purchase
Common Stock
2019-03-21$4.93/sh+1,000$4,930→ 7,118 total - Purchase
Common Stock
2019-03-21$4.87/sh+104$506→ 7,222 total